Pdc*line pharma

Pdc*line pharma

Verified
Biotech company that is developing a novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
EBITDA<1m<1m<1m<1m(1m)--
Profit<1m<1m<1m1m<1m--
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
€50kGrant
€4mSeries A
*
€20mSeries B
*
€17.5m
Valuation: €100m
Series B
Total Funding$45.7m

Recent News about Pdc*line pharma

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.